Grants and Contributions:
Title:
ARP - Evidence of performance - mobile hyperbaric chamber
Agreement Number:
905017
Agreement Value:
$7,168.40
Agreement Date:
Apr 2, 2018 - Mar 8, 2019
Description:
In order to obtain the right to sell to the U.S., the company must perform several destructive tests according to the guidelines prescribed by the FDA. The project consist of carrying out all activities required to allow a regulatory first sale in the U.S.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Terrebonne, Quebec, CA J6X 4P4
Reference Number:
172-2018-2019-Q1-905017
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
899599104
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is -35,731.6 dollars.
Amendment Date
Feb 12, 2019
Recipient's Legal Name:
Groupe Médical Gaumond inc.
Federal Riding Name:
Terrebonne
Federal Riding Number:
24075
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
32619
Amendments: